United Services Automobile Association Boosts Stake in ICU Medical, Incorporated (ICUI)

United Services Automobile Association grew its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 8.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,533 shares of the medical instruments supplier’s stock after purchasing an additional 289 shares during the period. United Services Automobile Association’s holdings in ICU Medical were worth $811,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. We Are One Seven LLC acquired a new stake in shares of ICU Medical in the 4th quarter worth about $32,000. Financial Gravity Companies Inc. acquired a new stake in shares of ICU Medical in the 4th quarter worth about $45,000. Bogart Wealth LLC acquired a new stake in shares of ICU Medical in the 4th quarter worth about $51,000. Huntington National Bank raised its holdings in shares of ICU Medical by 26.6% in the 4th quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 93 shares during the last quarter. Finally, Ffcm LLC acquired a new stake in shares of ICU Medical in the 4th quarter worth about $144,000. Hedge funds and other institutional investors own 92.78% of the company’s stock.

In other news, VP Virginia Ruth Sanzone sold 5,277 shares of the stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $232.31, for a total transaction of $1,225,899.87. Following the completion of the transaction, the vice president now directly owns 13,167 shares of the company’s stock, valued at approximately $3,058,825.77. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert S. Swinney sold 1,500 shares of the stock in a transaction that occurred on Monday, January 28th. The shares were sold at an average price of $242.19, for a total transaction of $363,285.00. Following the transaction, the director now directly owns 19,540 shares of the company’s stock, valued at $4,732,392.60. The disclosure for this sale can be found here. Insiders have sold a total of 8,470 shares of company stock valued at $1,985,710 over the last three months. Insiders own 11.40% of the company’s stock.

A number of research firms recently weighed in on ICUI. BidaskClub upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, February 20th. Raymond James reduced their price objective on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research report on Friday, March 1st. TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research report on Tuesday, March 19th. Finally, Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price objective for the company in a research report on Thursday, March 7th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $281.00.

ICUI stock traded down $3.53 during trading on Friday, reaching $221.79. The stock had a trading volume of 282,744 shares, compared to its average volume of 223,992. ICU Medical, Incorporated has a one year low of $210.94 and a one year high of $321.70. The company has a market capitalization of $4.57 billion, a price-to-earnings ratio of 28.77 and a beta of 0.74.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, February 28th. The medical instruments supplier reported $1.78 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.56 by $0.22. ICU Medical had a net margin of 2.06% and a return on equity of 13.31%. The business had revenue of $340.38 million during the quarter, compared to the consensus estimate of $314.60 million. As a group, research analysts predict that ICU Medical, Incorporated will post 8.58 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “United Services Automobile Association Boosts Stake in ICU Medical, Incorporated (ICUI)” was originally published by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/icu-medical-incorporated-icui-stake-increased-by-united-services-automobile-association.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Story: Relative Strength Index

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.